Behandling av icke spridd prostatacancer – individuellt val
(2024) In Lakartidningen 121.- Abstract
There is a long history of curative treatment of prostate cancer. However, as prostate cancer often grows very slowly, and symptoms do not have time to develop during a person's lifetime, a more tentative approach has become more and more common in many cases. This may be through either watchful waiting or active surveillance. In the first case palliative hormonal treatment is given in the case of progression, in the latter curative treatment would be the choice. When treatment is deemed necessary for localized disease, surgery and radiotherapy are considered equivalent in terms of efficacy and overall risk of side effects. For locally advanced disease, radiotherapy is the recommended first-hand choice outside the SPCG 15 study. Focal... (More)
There is a long history of curative treatment of prostate cancer. However, as prostate cancer often grows very slowly, and symptoms do not have time to develop during a person's lifetime, a more tentative approach has become more and more common in many cases. This may be through either watchful waiting or active surveillance. In the first case palliative hormonal treatment is given in the case of progression, in the latter curative treatment would be the choice. When treatment is deemed necessary for localized disease, surgery and radiotherapy are considered equivalent in terms of efficacy and overall risk of side effects. For locally advanced disease, radiotherapy is the recommended first-hand choice outside the SPCG 15 study. Focal treatment, which may lead to less side effects than surgery or radiotherapy, is not recommended outside trial settings due to lack of long-term follow-up data.
(Less)
- author
- Stranne, Johan ; Carlsson, Stefan ; Gunnlaugsson, Adalsteinn LU ; Kindblom, Jon ; Lantz, Anna and Bratt, Ola
- organization
- alternative title
- Treatment of non-metastatic prostate cancer
- publishing date
- 2024-04-22
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Lakartidningen
- volume
- 121
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:38650398
- scopus:85191408115
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- id
- 850abdae-d2ae-403a-a0b1-0f8c4912fdaa
- alternative location
- https://lakartidningen.se/klinik-och-vetenskap-1/artiklar-1/temaartikel/2024/04/behandling-av-icke-spridd-prostatacancer-individuellt-val/
- date added to LUP
- 2024-05-06 10:53:25
- date last changed
- 2024-05-06 10:54:41
@article{850abdae-d2ae-403a-a0b1-0f8c4912fdaa,
abstract = {{<p>There is a long history of curative treatment of prostate cancer. However, as prostate cancer often grows very slowly, and symptoms do not have time to develop during a person's lifetime, a more tentative approach has become more and more common in many cases. This may be through either watchful waiting or active surveillance. In the first case palliative hormonal treatment is given in the case of progression, in the latter curative treatment would be the choice. When treatment is deemed necessary for localized disease, surgery and radiotherapy are considered equivalent in terms of efficacy and overall risk of side effects. For locally advanced disease, radiotherapy is the recommended first-hand choice outside the SPCG 15 study. Focal treatment, which may lead to less side effects than surgery or radiotherapy, is not recommended outside trial settings due to lack of long-term follow-up data.</p>}},
author = {{Stranne, Johan and Carlsson, Stefan and Gunnlaugsson, Adalsteinn and Kindblom, Jon and Lantz, Anna and Bratt, Ola}},
issn = {{0023-7205}},
language = {{swe}},
month = {{04}},
publisher = {{Swedish Medical Association}},
series = {{Lakartidningen}},
title = {{Behandling av icke spridd prostatacancer – individuellt val}},
url = {{https://lakartidningen.se/klinik-och-vetenskap-1/artiklar-1/temaartikel/2024/04/behandling-av-icke-spridd-prostatacancer-individuellt-val/}},
volume = {{121}},
year = {{2024}},
}